New Drugs in Select Gastrointestinal Disorders
University of the Pacific
April 17-18 & April 24-25, 2021
Date of Presentation
Discuss broadly the clinical presentation and diagnostic criteria related to irritable bowel disease (IBS) and inflammatory bowel disease (IBD). Identify the new drugs which have been approved for IBS and IBD. Discuss the mechanism of action, adverse drug reactions, and monitoring parameters associated with each new drug. Discuss the clinical role and place in therapy of new drugs approved for IBS and IBD.
Vyas, Deepti, "New Drugs in Select Gastrointestinal Disorders" (2021). School of Pharmacy Faculty Presentations. 728.